IP Library › Granted Patent US 12,281,166
Granted Patent B2
US 12,281,166 · App. 17/303,268 · Granted Apr 22, 2025

Methods of treating inflammatory diseases by blocking Galectin-3

Inventors: Dongxu Sun (Los Altos, CA); Catherine A. Gordon (Fremont, CA); Ksenya Shchors (San Mateo, CA); Yan Wang (Concord, CA); Tsung-Huang Tsai (San Carlos, CA); Yew Ann Leong (San Francisco, CA)
Assignee: TrueBinding, Inc.
C07K16/2851A61K39/395A61P19/04A61P31/14A61P37/06A61K2039/505C07K2317/56C07K2317/565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,281,166
App. No.
17/303,268
Granted
Apr 22, 2025
Kind
B2
Abstract

Disclosed herein are methods, antibodies, and compositions for disrupting an interaction between Galectin-3 (Gal3) and viral proteins, such as proteins of the SARS-CoV-2 virus or other coronaviruses, or viral-associated host proteins. Further disclosed herein are methods, medicaments, and compositions for the treatment of a disease or a disorder in a subject, such as the treatment of a viral infection, or treatment of a fibrosis, such as lung fibrosis, that develop as a sequela of a viral infection, or cytokine release syndrome. Further disclosed herein are methods, medicaments, and compositions for the treatment of an inflammatory disease or disorder, such as inflammation of the lungs or systemic lupus erythematosus, which may be associated with neutrophil activity, in a subject. Also disclosed herein are pharmaceutical antibody formulations for the treatment of a disease, such as a coronavirus infection.

Claims (20)

1. A method of decreasing or inhibiting inflammation in a subject in need thereof, the method comprising:

administering to the subject an effective amount of an anti-Gal3 antibody or binding fragment thereof; wherein

the anti-Gal3 antibody or binding fragment thereof comprises (1) a light chain variable region comprising a V L -CDR1, a V L -CDR2, and a V L -CDR3; and (2) a heavy chain variable region comprising a V H -CDR1, a V H -CDR2, and a V H -CDR3, wherein

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 171, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 222, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 249; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 31, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 72, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 113; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 195, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 247, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 292; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 39, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 103, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 165; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 216, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 230, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 267; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 67, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 82, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 166; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 192, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 236, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 270; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 68, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 82, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 167; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 217, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 229, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 293; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 69, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 109, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 168; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 218, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 237, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 294; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 69, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 109, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 168; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 219, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 225, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 295; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 70, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 110, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 169; or

the V L -CDR1 comprises an amino acid that comprise SEQ ID NO: 220, the V L -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 227, the V L -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 296; the V H -CDR1 comprises an amino acid that comprise SEQ ID NO: 43, the V H -CDR2 comprises an amino acid sequence that comprise SEQ ID NO: 111, and the V H -CDR3 comprises an amino acid sequence that comprise SEQ ID NO: 138; and wherein

administration of the effective amount of the anti-Gal3 antibody or binding fragment thereof decreases or inhibits neutrophil activation and/or migration in the subject, decreases or inhibits cleavage of CD62L expressed by neutrophils, decreases or inhibits IL-8 production in the subject, decreases the number of neutrophils in the subject, and/or modulates expression of myeloperoxidase (MPO), growth-related oncogene α (GROα)/keratinocytes-derived chemokine (KC), Ly6c1, INOS, IL-6, TNFα, IL-1B, Col1A1, aSMA, TGFβ, VEGFA, VEGFB, or any combination thereof, in the subject.

2. The method of claim 1 , wherein the inflammation in the subject is associated with neutrophil activation and/or migration.

3. The method of claim 1 , further comprising detecting a decrease in neutrophil CD62L cleavage, a decrease in IL-8 production in the subject, a decrease in the number of neutrophils in the subject, or any combination thereof, a change in expression of Gal3, MPO, GROα/KC, Ly6c1, INOS, IL-6, TNFα, IL-1B, Col1A1, aSMA, TGFβ, VEGFA, VEGFB, or any combination thereof, in the subject, and/or an improvement in the inflammation in the subject, after the administering step.

4. The method of claim 1 , wherein administration of the effective amount of the anti-Gal3 antibody or binding fragment thereof decreases production of autoantibodies in the subject.

5. The method of claim 4 , wherein the autoantibodies are anti-nucleic acid autoantibodies.

6. The method of claim 1 , wherein the inflammation comprises lung inflammation, COPD, pneumonitis, asthma, sarcoidosis, pulmonary fibrosis, histiocytosis, bronchiolitis obliterans, or any combination thereof.

7. The method of claim 1 , wherein the inflammation comprises an autoimmune disease, systemic lupus erythematosus (SLE), Graves' disease, rheumatoid arthritis, multiple sclerosis, Sjogren's syndrome, celiac disease, or any combination thereof.

8. The method of claim 1 , wherein the anti-Gal3 antibody or binding fragment thereof binds to Peptide 4 (GAGGYPGASYPGAYPGQAPP; SEQ ID NO: 6), Peptide 6 (GAYPGQAPPGAYPGAPGAYP; SEQ ID NO: 8), or Peptide 7 (AYPGAPGAYPGAPAPGVYPG; SEQ ID NO: 9).

9. The method of claim 1 , wherein the anti-Gal3 antibody or binding fragment thereof is selected from the group consisting of: TB006, 849.5H1, 847.23F11, 847.16D10, 847.13E2-mH0mL1, 847.13E2-mH0mL2, 847.12C4, 847.4D3, or binding fragment thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2025
From: TSAI, TSUNG-HUANG
To: IMMUTICS, INC.
Reel/Frame 070438/0754 →
CHANGE OF NAME Recorded Mar 7, 2025
From: IMMUTICS, INC.
To: TRUEBINDING, INC.
Reel/Frame 070446/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2023
From: SUN, DONGXU; GORDON, CATHERINE A.; SHCHORS, KSENYA; WANG, YAN; LEONG, YEW ANN
To: TRUEBINDING, INC.
Reel/Frame 063332/0340 →
Continuity (2)
Provisional Application 63030069 · May 26, 2020
Related Publication 20210371533A1 · Dec 2, 2021
References Cited (400)
US 4179337A · Davis et al. · 1979 [cited by applicant]
US 4301144A · Washita et al. · 1981 [cited by applicant]
US 4495285A · Shimizu et al. · 1985 [cited by applicant]
US 4496689A · Mitra · 1985 [cited by applicant]
US 4609546A · Hiratani · 1986 [cited by applicant]
US 4640835A · Shimizu et al. · 1987 [cited by applicant]
US 4670417A · Iwasaki et al. · 1987 [cited by applicant]
US 4766106A · Katre et al. · 1988 [cited by applicant]
US 4791192A · Nakagawa et al. · 1988 [cited by applicant]
US 5208020A · Chari et al. · 1993 [cited by applicant]
US 5229275A · Goroff · 1993 [cited by applicant]
US 5270202A · Raychaudhuri · 1993 [cited by applicant]
US 5405783A · Pirrung et al. · 1995 [cited by applicant]
US 5412087A · McGall et al. · 1995 [cited by applicant]
US 5416064A · Chari et al. · 1995 [cited by applicant]
US 5445934A · Fodor et al. · 1995 [cited by applicant]
US 5567610A · Borrebaeck et al. · 1996 [cited by applicant]
US 5624659A · Bigner et al. · 1997 [cited by applicant]
US 5695937A · Kinzler et al. · 1997 [cited by applicant]
US 5928885A · Nixon et al. · 1999 [cited by applicant]
US 5936078A · Kuga et al. · 1999 [cited by applicant]
US 5948626A · Hawkins et al. · 1999 [cited by applicant]
US 5968797A · Ni et al. · 1999 [cited by applicant]
US 5969108A · McCafferty et al. · 1999 [cited by applicant]
US 5985660A · Galy · 1999 [cited by applicant]
US 5994084A · Anderton et al. · 1999 [cited by applicant]
US 6087153A · Greenwald et al. · 2000 [cited by applicant]
US 6150584A · Kucherlapati et al. · 2000 [cited by applicant]
US 6156311A · Strickland et al. · 2000 [cited by applicant]
US 6162963A · Kucherlapati et al. · 2000 [cited by applicant]
US 6174708B1 · Sodoyer et al. · 2001 [cited by applicant]
US 6187287B1 · Leung et al. · 2001 [cited by applicant]
US 6242421B1 · Bowen et al. · 2001 [cited by applicant]
US 6255054B1 · Hugon et al. · 2001 [cited by applicant]
US 6303576B1 · Blaschuk et al. · 2001 [cited by applicant]
US 6562806B1 · Thurston et al. · 2003 [cited by applicant]
US 6576607B1 · Schachner · 2003 [cited by applicant]
US 6608192B1 · Thurston et al. · 2003 [cited by applicant]
US 6677116B1 · Blaschuk et al. · 2004 [cited by applicant]
US 6716821B2 · Zhao et al. · 2004 [cited by applicant]
US 6727075B2 · Fitzgerald et al. · 2004 [cited by applicant]
US 6821783B1 · Comely et al. · 2004 [cited by applicant]
US 6825164B1 · Stern et al. · 2004 [cited by applicant]
US 6852482B1 · Chrysler et al. · 2005 [cited by applicant]
US 6884869B2 · Senter et al. · 2005 [cited by applicant]
US 6982089B2 · Tobinick et al. · 2006 [cited by applicant]
US 7014855B2 · Schenk · 2006 [cited by applicant]
US 7029860B2 · Ota et al. · 2006 [cited by applicant]
US 7049311B1 · Thurston et al. · 2006 [cited by applicant]
US 7067511B2 · Thurston et al. · 2006 [cited by applicant]
US 7115260B2 · Dixit et al. · 2006 [cited by applicant]
US 7214715B2 · Beck et al. · 2007 [cited by applicant]
US 7244724B2 · Liu et al. · 2007 [cited by applicant]
US 7270818B2 · Averback · 2007 [cited by applicant]
US 7276497B2 · Chari et al. · 2007 [cited by applicant]
US 7409040B2 · Cyrulnik · 2008 [cited by applicant]
US 7416855B2 · He et al. · 2008 [cited by applicant]
US 7485712B2 · Mandelkow et al. · 2009 [cited by applicant]
US 7498298B2 · Doronina et al. · 2009 [cited by applicant]
US 7528126B2 · Howard et al. · 2009 [cited by applicant]
US 7582732B2 · Horie et al. · 2009 [cited by applicant]
US 7611910B2 · Balin et al. · 2009 [cited by applicant]
US 7612062B2 · Gregson et al. · 2009 [cited by applicant]
US 7659241B2 · Senter et al. · 2010 [cited by applicant]
US 7662816B2 · Cumming et al. · 2010 [cited by applicant]
US 7700823B2 · Casas et al. · 2010 [cited by applicant]
US 7704924B2 · Thurston et al. · 2010 [cited by applicant]
US 7732568B2 · Mattner · 2010 [cited by applicant]
US 7750116B1 · Doronina et al. · 2010 [cited by applicant]
US 7846679B2 · St. George-Hyslop et al. · 2010 [cited by applicant]
US 7858642B2 · John et al. · 2010 [cited by applicant]
US 7910590B2 · Huang et al. · 2011 [cited by applicant]
US 7935252B2 · Mattner et al. · 2011 [cited by applicant]
US 7935348B2 · Mattner et al. · 2011 [cited by applicant]
US 7951373B2 · Schachner · 2011 [cited by applicant]
US 7955812B2 · Moir et al. · 2011 [cited by applicant]
US 7964566B2 · Doronina et al. · 2011 [cited by applicant]
US 7989597B2 · Chang et al. · 2011 [cited by applicant]
US 8008449B2 · Korman et al. · 2011 [cited by applicant]
US 8022180B2 · Mattner et al. · 2011 [cited by applicant]
US 8034353B2 · Yano et al. · 2011 [cited by applicant]
US 8060179B1 · Flynn · 2011 [cited by applicant]
US 8105597B2 · Davies et al. · 2012 [cited by applicant]
US 8105839B2 · Urakami et al. · 2012 [cited by applicant]
US 8163736B2 · Gauzy et al. · 2012 [cited by applicant]
US 8168188B1 · Hoshi et al. · 2012 [cited by applicant]
US 8173775B2 · Iwatsubo et al. · 2012 [cited by applicant]
US 8222002B2 · Sugimura et al. · 2012 [cited by applicant]
US 8232373B2 · Wang · 2012 [cited by applicant]
US 8257740B1 · Sung et al. · 2012 [cited by applicant]
US 8263558B2 · Holzman et al. · 2012 [cited by applicant]
US 8288352B2 · Doronina et al. · 2012 [cited by applicant]
US 8318171B2 · Bush et al. · 2012 [cited by applicant]
US 8318687B2 · Tabira et al. · 2012 [cited by applicant]
US 8323925B2 · Chakravarthy · 2012 [cited by applicant]
US 8338379B2 · Yamaguchi et al. · 2012 [cited by applicant]
US 8343493B2 · VanMechelen et al. · 2013 [cited by applicant]
US 8357781B2 · Johnson-Wooed et al. · 2013 [cited by applicant]
US 8394380B2 · Manucharyan et al. · 2013 [cited by applicant]
US 8404678B2 · Bouchard et al. · 2013 [cited by applicant]
US 8409575B2 · Lannfelt et al. · 2013 [cited by applicant]
US 8426402B2 · Li et al. · 2013 [cited by applicant]
US 8481701B2 · Jarrige et al. · 2013 [cited by applicant]
US 8487099B2 · Greenlee et al. · 2013 [cited by applicant]
US 8501934B2 · Howard et al. · 2013 [cited by applicant]
US 8518975B2 · Aslanian et al. · 2013 [cited by applicant]
US 8613920B2 · Lieberburg et al. · 2013 [cited by applicant]
US 8617549B2 · Sierks et al. · 2013 [cited by applicant]
US 8618123B2 · Sasikumar et al. · 2013 [cited by applicant]
US 8623365B2 · Davies et al. · 2014 [cited by applicant]
US 8633185B2 · Howard et al. · 2014 [cited by applicant]
US 8642044B2 · Schenk et al. · 2014 [cited by applicant]
US 8663650B2 · Nicolau et al. · 2014 [cited by applicant]
US 8664411B2 · Wu et al. · 2014 [cited by applicant]
US 8697688B2 · Howard et al. · 2014 [cited by applicant]
US 8703714B2 · Doronina et al. · 2014 [cited by applicant]
US 8710193B2 · Irie et al. · 2014 [cited by applicant]
US 8722042B2 · Relkin · 2014 [cited by applicant]
US 8748386B2 · Sigurdsson · 2014 [cited by applicant]
US 8778885B2 · Cashman et al. · 2014 [cited by applicant]
US 8784810B2 · Lieberburg et al. · 2014 [cited by applicant]
US 8796319B2 · Combs et al. · 2014 [cited by applicant]
US 8802667B2 · Li et al. · 2014 [cited by applicant]
US 8809010B2 · Hoffmann et al. · 2014 [cited by applicant]
US 8809320B2 · Li et al. · 2014 [cited by applicant]
US 8852874B2 · Olas et al. · 2014 [cited by applicant]
US 8871720B2 · Doronina et al. · 2014 [cited by applicant]
US 8877192B2 · Mjalli et al. · 2014 [cited by applicant]
US 8877207B2 · Cimini et al. · 2014 [cited by applicant]
US 8912145B2 · Terakawa et al. · 2014 [cited by applicant]
US 8933295B2 · Jung et al. · 2015 [cited by applicant]
US 8936910B2 · Mitsch et al. · 2015 [cited by applicant]
US 8993833B2 · Colton et al. · 2015 [cited by applicant]
US 9034334B2 · Gellerfors et al. · 2015 [cited by applicant]
US 9066928B1 · Estus et al. · 2015 [cited by applicant]
US 9089614B2 · Lin et al. · 2015 [cited by applicant]
US 9133267B2 · Lee et al. · 2015 [cited by applicant]
US 9163062B2 · Sarasa Barrio · 2015 [cited by applicant]
US 9173928B2 · Matsumoto · 2015 [cited by applicant]
US 9217036B2 · Strittmatter et al. · 2015 [cited by applicant]
US 9234038B2 · Jung et al. · 2016 [cited by applicant]
US 9242013B2 · Howard et al. · 2016 [cited by applicant]
US 9295707B2 · Shashoua · 2016 [cited by applicant]
US 9320436B2 · Russmann et al. · 2016 [cited by applicant]
US 9347085B2 · Gan et al. · 2016 [cited by applicant]
US 9382316B2 · Yoon · 2016 [cited by applicant]
US 9580494B2 · Shafer et al. · 2017 [cited by applicant]
US 9618511B2 · Querfurth · 2017 [cited by applicant]
US 9637552B2 · Cashman et al. · 2017 [cited by applicant]
US 9645155B2 · Cai et al. · 2017 [cited by applicant]
US 9737505B2 · Denis et al. · 2017 [cited by applicant]
US 9751912B2 · Hoshi · 2017 [cited by applicant]
US 9757398B2 · Vigo et al. · 2017 [cited by applicant]
US 9777056B2 · Sigurdsson et al. · 2017 [cited by applicant]
US 9790253B2 · Shair et al. · 2017 [cited by applicant]
US 9821114B2 · Cabrera Aquino et al. · 2017 [cited by applicant]
US 9879076B2 · Samira et al. · 2018 [cited by applicant]
US 9907485B2 · Hartlep et al. · 2018 [cited by applicant]
US 9933440B2 · Goetzl · 2018 [cited by applicant]
US 9937248B2 · Arya · 2018 [cited by applicant]
US 9999624B2 · May et al. · 2018 [cited by applicant]
US 10011653B2 · Hayashi et al. · 2018 [cited by applicant]
US 10028962B2 · Brodney et al. · 2018 [cited by applicant]
US 10117895B2 · Monsonego · 2018 [cited by applicant]
US 10131708B2 · Nitsch et al. · 2018 [cited by applicant]
US 10203342B2 · Goetzl · 2019 [cited by applicant]
US 10232056B2 · Uchida et al. · 2019 [cited by applicant]
US 10282349B2 · Jaffee · 2019 [cited by applicant]
US 10323084B2 · Hillen et al. · 2019 [cited by applicant]
US 10358503B2 · Sigurdsson · 2019 [cited by applicant]
US 10364286B2 · Fog et al. · 2019 [cited by applicant]
US 10377834B2 · De Strooper et al. · 2019 [cited by applicant]
US 10393757B2 · Hashimoto et al. · 2019 [cited by applicant]
US 10420923B1 · Katz · 2019 [cited by applicant]
US 10421958B2 · Poma et al. · 2019 [cited by applicant]
US 10472414B2 · Christensen et al. · 2019 [cited by applicant]
US 10473672B2 · Lin et al. · 2019 [cited by applicant]
US 10532104B2 · Elmaleh · 2020 [cited by applicant]
US 10570196B2 · Ghochikyan et al. · 2020 [cited by applicant]
US 10654917B2 · Volker et al. · 2020 [cited by applicant]
US 10662226B2 · Nowick et al. · 2020 [cited by applicant]
US 10662239B2 · Groves et al. · 2020 [cited by applicant]
US 10662246B2 · Wisniewski et al. · 2020 [cited by applicant]
US 10670613B2 · Umek et al. · 2020 [cited by applicant]
US 10718785B2 · Pike et al. · 2020 [cited by applicant]
US 10730937B2 · Okazawa et al. · 2020 [cited by applicant]
US 10738107B2 · Gnauer et al. · 2020 [cited by applicant]
US 10815230B2 · Pike et al. · 2020 [cited by applicant]
US 10815469B2 · Poma et al. · 2020 [cited by applicant]
US 10822402B2 · Dengl et al. · 2020 [cited by applicant]
US 10836814B2 · Goshima et al. · 2020 [cited by applicant]
US 10842871B2 · Ferrero et al. · 2020 [cited by applicant]
US 10851156B2 · Mercken et al. · 2020 [cited by applicant]
US 10859582B2 · Sigurdsson et al. · 2020 [cited by applicant]
US 10874725B2 · Henco et al. · 2020 [cited by applicant]
US 10888600B2 · Tanzi et al. · 2021 [cited by applicant]
US 10894822B2 · Chain · 2021 [cited by applicant]
US 10919971B2 · Collinge et al. · 2021 [cited by applicant]
US 10934348B2 · Pedersen et al. · 2021 [cited by applicant]
US 10941205B2 · Duerr et al. · 2021 [cited by applicant]
US 10941215B2 · Dennis et al. · 2021 [cited by applicant]
US 10954306B2 · Greenfield et al. · 2021 [cited by applicant]
US 10976319B2 · Pugia · 2021 [cited by applicant]
US 10981989B2 · Eisenbach et al. · 2021 [cited by applicant]
US 10988528B2 · Sigurdsson · 2021 [cited by applicant]
US 11084873B2 · Shie et al. · 2021 [cited by applicant]
US 11085935B2 · Barthelemy et al. · 2021 [cited by applicant]
US 11098106B2 · Novák et al. · 2021 [cited by applicant]
US 11111290B2 · Pedersen et al. · 2021 [cited by applicant]
US 11135313B2 · Wilson et al. · 2021 [cited by applicant]
US 11181533B2 · Shi et al. · 2021 [cited by applicant]
US 11214835B1 · Patel et al. · 2022 [cited by applicant]
US 11219627B2 · Davis et al. · 2022 [cited by applicant]
US 11236155B2 · Van et al. · 2022 [cited by applicant]
US 11278620B2 · Liang et al. · 2022 [cited by applicant]
US 11286297B2 · Groves et al. · 2022 [cited by applicant]
US 11312751B2 · Poma et al. · 2022 [cited by applicant]
US 11319372B2 · Calzone et al. · 2022 [cited by applicant]
US 11365223B2 · Poma et al. · 2022 [cited by applicant]
US 11370833B2 · Le et al. · 2022 [cited by applicant]
US 11389476B2 · Eliaz · 2022 [cited by applicant]
US 11395796B2 · Romanelli et al. · 2022 [cited by applicant]
US 11396553B2 · Oostindie et al. · 2022 [cited by applicant]
US 11413282B2 · Sampath et al. · 2022 [cited by applicant]
US 11427638B2 · Sun · 2022 [cited by examiner]
US 11434302B2 · Raum et al. · 2022 [cited by applicant]
US 11439665B2 · Yao et al. · 2022 [cited by applicant]
US 11446398B2 · Barrett et al. · 2022 [cited by applicant]
US 11459404B2 · Bacac et al. · 2022 [cited by applicant]
US 11459405B2 · Sasisekharan et al. · 2022 [cited by applicant]
US 11466099B2 · Garcia et al. · 2022 [cited by applicant]
US 11471490B2 · Andresen et al. · 2022 [cited by applicant]
US 11472858B2 · Yao et al. · 2022 [cited by applicant]
US 11478554B2 · Lerchen et al. · 2022 [cited by applicant]
US 11505609B2 · Qin et al. · 2022 [cited by applicant]
US 11512137B2 · Oostindie et al. · 2022 [cited by applicant]
US 11518810B2 · Song et al. · 2022 [cited by applicant]
US 11525007B2 · Bruenker et al. · 2022 [cited by applicant]
US 11535838B2 · Rosenblum et al. · 2022 [cited by applicant]
US 11583594B2 · Xie · 2023 [cited by applicant]
US 11584793B2 · Dengl et al. · 2023 [cited by applicant]
US 11590128B2 · Sampath et al. · 2023 [cited by applicant]
US 11596699B2 · Fotin-Mleczek · 2023 [cited by applicant]
US 11597772B2 · Oestergaard et al. · 2023 [cited by applicant]
US 11603411B2 · Duerr et al. · 2023 [cited by applicant]
US 11608369B2 · Yao et al. · 2023 [cited by applicant]
US 11608376B2 · Georges et al. · 2023 [cited by applicant]
US 11618778B2 · Yao et al. · 2023 [cited by applicant]
US 11633430B2 · Yao et al. · 2023 [cited by applicant]
US 11634486B2 · Jefferies et al. · 2023 [cited by applicant]
US 11654143B2 · Hamdy et al. · 2023 [cited by applicant]
US 11660351B2 · Lerchen et al. · 2023 [cited by applicant]
US 11666642B2 · Suri et al. · 2023 [cited by applicant]
US 11679127B2 · Stubenrauch et al. · 2023 [cited by applicant]
US 11685714B2 · Lerchen et al. · 2023 [cited by applicant]
US 11713358B2 · Schellenberger et al. · 2023 [cited by applicant]
US 11718680B2 · Bacac et al. · 2023 [cited by applicant]
US 11746161B2 · Chen et al. · 2023 [cited by applicant]
US 11753466B2 · West et al. · 2023 [cited by applicant]
US 11768203B2 · Chaudhary · 2023 [cited by applicant]
US 11771696B2 · Hamdy et al. · 2023 [cited by applicant]
US 11788205B2 · Klein et al. · 2023 [cited by applicant]
US 11833214B2 · Hilderbrand et al. · 2023 [cited by applicant]
US 11857628B2 · Poma et al. · 2024 [cited by applicant]
US 11866507B2 · Eckelman · 2024 [cited by applicant]
US 11867696B2 · Schwartz · 2024 [cited by applicant]
US 11873332B2 · Soto et al. · 2024 [cited by applicant]
US 11873342B2 · Li et al. · 2024 [cited by applicant]
US 11891444B2 · Gauthier et al. · 2024 [cited by applicant]
US 11912759B2 · Liu et al. · 2024 [cited by applicant]
US 11913945B2 · Schaefer et al. · 2024 [cited by applicant]
US 20030133939A1 · Ledbetter et al. · 2003 [cited by applicant]
US 20040022397A1 · Warren · 2004 [cited by applicant]
US 20050032673A1 · John et al. · 2005 [cited by applicant]
US 20050158321A1 · Hurez et al. · 2005 [cited by applicant]
US 20060240551A1 · Jiang · 2006 [cited by applicant]
US 20060257359A1 · Francois et al. · 2006 [cited by applicant]
US 20090269779A1 · Raz et al. · 2009 [cited by applicant]
US 20090280116A1 · Smith et al. · 2009 [cited by applicant]
US 20090311193A1 · Mauro et al. · 2009 [cited by applicant]
US 20100061992A1 · Anderson et al. · 2010 [cited by applicant]
US 20100143954A1 · Muntendam · 2010 [cited by applicant]
US 20100196882A1 · Raz et al. · 2010 [cited by applicant]
US 20100330602A1 · Van Meir et al. · 2010 [cited by applicant]
US 20110038861A1 · Rosenthal et al. · 2011 [cited by applicant]
US 20110293608A1 · Jaffee · 2011 [cited by applicant]
US 20120225114A1 · Francois et al. · 2012 [cited by applicant]
US 20120253160A1 · Mauro et al. · 2012 [cited by applicant]
US 20130029900A1 · Widdison · 2013 [cited by applicant]
US 20130029955A1 · Muntendam · 2013 [cited by applicant]
US 20130323268A1 · Chari et al. · 2013 [cited by applicant]
US 20140086836A1 · Burnham et al. · 2014 [cited by applicant]
US 20140086932A1 · Traber · 2014 [cited by applicant]
US 20140099254A1 · Chang et al. · 2014 [cited by applicant]
US 20140235495A1 · Pugia · 2014 [cited by applicant]
US 20140286970A1 · Jeffrey et al. · 2014 [cited by applicant]
US 20140294868A1 · Howard et al. · 2014 [cited by applicant]
US 20150105539A1 · Miao et al. · 2015 [cited by applicant]
US 20150105540A1 · Miao et al. · 2015 [cited by applicant]
US 20150150945A1 · Francois et al. · 2015 [cited by applicant]
US 20150218274A1 · Sabatos-Peyton et al. · 2015 [cited by applicant]
US 20150301058A1 · Schettini et al. · 2015 [cited by applicant]
US 20150329636A1 · Dennis et al. · 2015 [cited by applicant]
US 20160068577A1 · Poma et al. · 2016 [cited by applicant]
US 20160177284A1 · Poma et al. · 2016 [cited by applicant]
US 20160376328A1 · Poma et al. · 2016 [cited by applicant]
US 20170002046A1 · Poma et al. · 2017 [cited by applicant]
US 20170014446A1 · Rolke et al. · 2017 [cited by applicant]
US 20170153241A1 · Pugia · 2017 [cited by applicant]
US 20170355756A1 · Julien · 2017 [cited by applicant]
US 20180000899A1 · Francois et al. · 2018 [cited by applicant]
US 20180243432A1 · Poma et al. · 2018 [cited by applicant]
US 20180256747A1 · Hawthorne et al. · 2018 [cited by applicant]
US 20180291359A1 · Poma et al. · 2018 [cited by applicant]
US 20190153044A1 · Poma et al. · 2019 [cited by applicant]
US 20190175649A1 · Novik · 2019 [cited by applicant]
US 20190218300A1 · Del Rio et al. · 2019 [cited by applicant]
US 20190248902A1 · Nioi · 2019 [cited by applicant]
US 20190265235A1 · Schwartz et al. · 2019 [cited by applicant]
US 20190374650A1 · Moon et al. · 2019 [cited by applicant]
US 20200024312A1 · Poma et al. · 2020 [cited by applicant]
US 20200055938A1 · Desai · 2020 [cited by applicant]
US 20200223921A1 · Sun et al. · 2020 [cited by applicant]
US 20210132067A1 · Schwartz · 2021 [cited by applicant]
US 20210324056A1 · Luthman et al. · 2021 [cited by applicant]
US 20210401985A1 · Biel et al. · 2021 [cited by applicant]
US 20220025071A1 · Capon · 2022 [cited by applicant]
US 20220088013A1 · Hamdy et al. · 2022 [cited by applicant]
US 20220088195A1 · Klein et al. · 2022 [cited by applicant]
US 20220098329A1 · Santich et al. · 2022 [cited by applicant]
US 20220125942A1 · Musick et al. · 2022 [cited by applicant]
US 20220127366A1 · Fotakis et al. · 2022 [cited by applicant]
US 20220133711A1 · Chari et al. · 2022 [cited by applicant]
US 20220135678A1 · Chaudhary · 2022 [cited by applicant]
US 20220162316A1 · Pandit et al. · 2022 [cited by applicant]
US 20220168418A1 · Haefel et al. · 2022 [cited by applicant]
US 20220184127A1 · Wang et al. · 2022 [cited by applicant]
US 20220195043A1 · Li et al. · 2022 [cited by applicant]
US 20220195057A1 · Li et al. · 2022 [cited by applicant]
US 20220195071A1 · Jones · 2022 [cited by applicant]
US 20220204582A1 · Chaudhary · 2022 [cited by applicant]
US 20220211696A1 · Sampath et al. · 2022 [cited by applicant]
US 20220211865A1 · Fischer et al. · 2022 [cited by applicant]
US 20220226514A1 · Vasiljeva et al. · 2022 [cited by applicant]
US 20220233705A1 · Le Scolan et al. · 2022 [cited by applicant]
US 20220242936A1 · Feng et al. · 2022 [cited by applicant]
US 20220242949A1 · Desnoyers et al. · 2022 [cited by applicant]
US 20220244271A1 · Reed et al. · 2022 [cited by applicant]
US 20220251231A1 · Oostindie et al. · 2022 [cited by applicant]
US 20220257762A1 · Liang et al. · 2022 [cited by applicant]
US 20220259306A1 · Duan et al. · 2022 [cited by applicant]
US 20220259321A1 · Cascino · 2022 [cited by applicant]
US 20220265642A1 · Sampath et al. · 2022 [cited by applicant]
US 20220267460A1 · Lansing et al. · 2022 [cited by applicant]
US 20220275067A1 · Dolan, III et al. · 2022 [cited by applicant]
US 20220281945A1 · Yao et al. · 2022 [cited by applicant]
US 20220288123A1 · Yao et al. · 2022 [cited by applicant]
US 20220289173A1 · Sun et al. · 2022 [cited by applicant]
US 20220289858A1 · Benatuil et al. · 2022 [cited by applicant]
US 20220306761A1 · Duerr et al. · 2022 [cited by applicant]
US 20220324940A1 · Yao et al. · 2022 [cited by applicant]
US 20220332757A1 · Zhang et al. · 2022 [cited by applicant]
US 20220340640A1 · Yao et al. · 2022 [cited by applicant]
US 20220340677A1 · Zhang et al. · 2022 [cited by applicant]
US 20220354938A1 · Poma et al. · 2022 [cited by applicant]
US 20220357340A1 · Brady et al. · 2022 [cited by applicant]
US 20220363255A1 · Concas · 2022 [cited by applicant]
US 20220370441A1 · Sampath et al. · 2022 [cited by applicant]
US 20220372142A1 · Baliga et al. · 2022 [cited by applicant]
US 20220372156A1 · Lechner et al. · 2022 [cited by applicant]
US 20220380473A1 · Sun et al. · 2022 [cited by applicant]
US 20220380480A1 · Lechner et al. · 2022 [cited by applicant]
US 20220389116A1 · Klein et al. · 2022 [cited by applicant]
US 20220389449A1 · Paul et al. · 2022 [cited by applicant]
US 20220396632A1 · Novobrantseva et al. · 2022 [cited by applicant]
US 20220402998A1 · Liu et al. · 2022 [cited by applicant]
US 20220403001A1 · Suri et al. · 2022 [cited by applicant]
US 20220403027A1 · Ast et al. · 2022 [cited by applicant]
US 20220411514A1 · Sun et al. · 2022 [cited by applicant]
US 20230036181A1 · Sun et al. · 2023 [cited by applicant]
US 20230039927A1 · Cascino · 2023 [cited by applicant]
US 20230046007A1 · Bauer et al. · 2023 [cited by applicant]
US 20230048390A1 · Liebowitz · 2023 [cited by applicant]
US 20230052521A1 · Bacac et al. · 2023 [cited by applicant]
US 20230074330A1 · Suri et al. · 2023 [cited by applicant]
US 20230074657A1 · Song et al. · 2023 [cited by applicant]
US 20230081117A1 · Oakes et al. · 2023 [cited by applicant]
US 20230082273A1 · Song et al. · 2023 [cited by applicant]
US 20230084763A1 · Chen et al. · 2023 [cited by applicant]
US 20230091653A1 · Bindman et al. · 2023 [cited by applicant]
US 20230094463A1 · Sun et al. · 2023 [cited by applicant]
US 20230094471A1 · Chari et al. · 2023 [cited by applicant]
US 20230099756A1 · Hirata et al. · 2023 [cited by applicant]
US 20230103667A1 · Muntendam et al. · 2023 [cited by applicant]
US 20230104705A1 · Yao et al. · 2023 [cited by applicant]
US 20230107479A1 · Muntendam · 2023 [cited by applicant]
US 20230121775A1 · Schellenberger et al. · 2023 [cited by applicant]
US 20230140802A1 · Chaudhary · 2023 [cited by applicant]
US 20230151104A1 · Yan et al. · 2023 [cited by applicant]
US 20230190638A1 · Romanelli et al. · 2023 [cited by applicant]